As pancreatic and colorectal cancer disease-free survival time is positively correlated with CXCR5+ CD8 T cell frequency (30), the maintenance of a CXCR5+ CD8 T cell population may prolong cancer treatment efficacy. Here, CD8A is linked to cancer.